Ligand Pharmaceuticals Incorporated - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
LGND Nasdaq 2836 www.ligand.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ligand Pharmaceuticals Incorporated

Gamble on Huge Gains with These 3 Best Biotech Stocks to Buy for 2026 - Jan 12th, 2026 8:32 am
Dow Jones Futures Fall; Lockheed, Defense Giants Bounce On $1.5 Trillion Trump 'Dream Military' - Jan 8th, 2026 5:57 am
3 Stocks Estimated To Be Up To 36.7% Below Intrinsic Value Offering Potential Opportunities - Dec 18th, 2025 4:37 am
Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - Dec 17th, 2025 4:48 am
LGND: 2025 Analyst Day - Dec 15th, 2025 4:04 am
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance - Dec 9th, 2025 5:00 am
Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 92% This Year - Nov 20th, 2025 11:34 am
Ligand Pharmaceuticals (LGND): Assessing Valuation After Strong Recent Share Price Gains - Nov 20th, 2025 3:09 am
How Ligand Pharmaceuticals’ Strong Q3 Results and Raised Guidance May Impact LGND Investors - Nov 19th, 2025 4:14 pm
What Makes Ligand Pharmaceuticals (LGND) an Investment Choice? - Nov 19th, 2025 6:11 am
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates - Nov 10th, 2025 2:10 pm
LGND: Target Up On Improved Growth Outlook - Nov 10th, 2025 8:05 am
Pelthos acquires US rights to Xepi cream from Biofrontera and Ferrer - Nov 10th, 2025 3:31 am
Ligand Pharmaceuticals Incorporated Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Nov 9th, 2025 7:18 am
November 2025's Top Stocks Priced Below Estimated Value - Nov 7th, 2025 10:38 am
Ligand (LGND) Q3 2025 Earnings Call Transcript - Nov 6th, 2025 8:46 am
Ligand: Q3 Earnings Snapshot - Nov 6th, 2025 5:14 am
Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance - Nov 6th, 2025 5:00 am
How Investors Are Reacting To Ligand Pharmaceuticals (LGND) Management's Engagement Surge and Analyst Optimism - Nov 3rd, 2025 3:07 pm
Orchestra BioMed to Host Business Update Call on November 12, 2025 - Nov 3rd, 2025 6:00 am